Build is the one factor where carriers disagree most - which means it is also the one where shopping the file matters most.
Last reviewed September 2026 by Dev Gaymes, Licensed Insurance Advisor · Editorial policy
Height and weight appear on every application, and they carry more weight in the outcome than most people expect. But here is the part that matters: every carrier writes its own build chart, and they differ substantially. The same height and weight that draws a decline at one company can be issued at Standard by another.
BMI is the starting point, not the conclusion. It is a crude measure, underwriters know it, and most modern manuals look past it:
The practical consequence: two people at identical height and weight can land several rate classes apart. Build alone rarely decides the case.
General industry patterns, not promises. Every carrier publishes its own build chart and applies it case by case.
If you are taking semaglutide, tirzepatide or a similar medication, this is worth knowing, because the underwriting picture has shifted faster than most published guidance reflects.
Industry analysis covering roughly 41 million insured lives from 2015 through early 2025 found GLP-1 users showed lower all-cause mortality than non-users. Clinical data cited alongside it showed semaglutide associated with an approximately 20% reduction in major cardiovascular events and a 19% improvement in all-cause mortality.
Disclose it either way. These prescriptions appear in the databases carriers check, and an undisclosed one is a misstatement regardless of how it would have been rated.
Underwriters generally want to see that a change has held. Recent rapid loss - whatever the cause - is usually assessed cautiously until there is a stable period behind it, because carriers cannot distinguish intentional loss from illness on a single reading.
Sustained loss maintained over a year or more is a genuinely different file, and it is worth documenting rather than leaving the underwriter to infer it.
Carriers typically want to see the recovery period completed and weight stabilised - commonly around 12 to 24 months post-procedure, though this varies considerably. Once stable, outcomes are frequently better than the pre-surgery file would have produced, particularly where comorbidities resolved.
Applying during the first year is usually premature. The underwriter has no stable data point to price from, and the answer tends to be a postponement rather than an offer.
It rarely ends there. Final expense and simplified issue whole life carry far more lenient build limits, sometimes none at all, and guaranteed issue asks no health questions whatsoever.
Those products cost more per dollar of benefit and typically carry a two-year graded death benefit, so they are not equivalent to fully underwritten coverage. But they are real coverage, available now, and they do not prevent you from applying for something better later. More on how those products work.
In most cases yes. Many people with a medically overweight or obese BMI qualify for coverage - often at Standard, sometimes table rated, and occasionally at better classes than expected. Build is one factor among several, and what accompanies it usually matters more: blood pressure, cholesterol and blood sugar control frequently drive the outcome more than the number on the scale.
No, and this is the single most useful thing to know about build underwriting. Every company writes its own build chart, and they differ substantially. Someone at 5'8" and 240 pounds might be declined by one carrier and issued at Standard by another, on the same file. That spread is wider for build than for almost any other underwriting factor, which is why shopping the case matters here more than it does elsewhere.
No. BMI is a starting point and a crude one. Underwriters also consider build relative to frame, waist measurement where available, whether weight has been stable or climbing, your lab results, and any conditions that travel with elevated build. Muscular applicants with an overweight BMI frequently reach top rate classes once an underwriter sees the full picture rather than just the ratio.
It can, and increasingly in your favour. Industry analysis covering roughly 41 million insured lives from 2015 through early 2025 found GLP-1 users showed lower all-cause mortality than non-users, and clinical data associated semaglutide with about a 20% reduction in major cardiovascular events. Some carriers now read documented GLP-1 use as evidence of a managed condition with an improving trajectory; others still weight the underlying condition more heavily. The spread between those readings is large, which makes carrier selection important. Disclose the prescription either way - it appears in the databases carriers check.
Do not make decisions about your body for an insurance application. Underwriters generally assess recent rapid weight change cautiously until it has held, because they cannot distinguish intentional loss from illness on a single reading. Sustained change maintained over a year or more does read as a genuinely different file. But if your weight is changing under a physician's direction, that is a medical matter and applying once it stabilises is a conversation for you and your doctor - not a reason to alter anything.
Carriers typically want the recovery period completed and weight stabilised, commonly around 12 to 24 months post-procedure, though this varies considerably by carrier and by procedure. Applying during the first year usually results in postponement rather than an offer, because there is no stable data point to price from. Once stable, outcomes are frequently better than the pre-surgery file would have produced, particularly where related conditions resolved.
A decline is one carrier's answer under one carrier's build chart, and build is the factor where charts differ most. It says very little about what another company would do. That said, applying blindly elsewhere is the wrong next step, because a decline creates an MIB record the next carrier will see. Understanding which chart you fell outside of, and by how much, is what determines where the file should go next.
Yes. Final expense and simplified issue whole life carry far more lenient build limits, and some products have none at all. Guaranteed issue asks no health questions whatsoever. These cost more per dollar of benefit and typically carry a two-year graded death benefit, so they are not equivalent to fully underwritten coverage - but they are real coverage available now, and taking one does not prevent you from applying for something better later.
Dev Gaymes is a licensed insurance broker, not a physician. General education, not medical advice and not advice about your situation, and not an offer of insurance or a quote. Never change, start or stop any medication, diet or treatment plan for an insurance application or for any reason other than your physician’s direction. Height, weight and BMI thresholds referenced here describe general industry practice and are not any specific carrier’s chart. Nothing on this page is guidance on diet, exercise, weight management or the use of any medication. Underwriting guidelines - including build charts, thresholds and rate classes - vary by carrier, product and state, change over time, and are applied case by case at the underwriter’s discretion. Nothing here describes any particular insurer’s current guidelines or predicts your outcome. All coverage is subject to carrier underwriting approval, and policy terms, benefits, exclusions and limitations are governed solely by the issued policy contract. Always answer every application question completely and truthfully.
We’ll tell you where you’re likely to land before you apply anywhere.
Prefer to talk now? Call 214-989-7704